$25M$50M
$1M$10M
$1M
$10M$25M
$1M$10M
$1M$10M
$50M$100M| FoRx Therapeutics Email Formats | Percentage |
| First.Last@forxtherapeutics.com | 100% |
Biotechnology ResearchBasel, Switzerland11-50 Employees
FoRx Therapeutics is a recently incorporated privately-held company based in Basel, Switzerland. It is backed by a syndicate of investors that include the Novartis Venture Fund, Pfizer Ventures, M Ventures, Omega Funds and LSP Venture Capital. FoRx Therapeutics focuses on drugging key molecular targets involved in the DNA Replication Stress, as a new approach in the development of targeted anticancer drugs.
Company Overview
Funding & FinancialsFoRx Therapeutics has raised a total of $11M of funding over 1 rounds. Their latest funding round was raised on Apr 22, 2020 in the amount of $11M.
FoRx Therapeutics's revenue is estimated to be in the range of $10M$25M
Funding & FinancialsFoRx Therapeutics has raised a total of $11M of funding over 1 rounds. Their latest funding round was raised on Apr 22, 2020 in the amount of $11M.
FoRx Therapeutics's revenue is estimated to be in the range of $10M$25M
1-888-653-2347 
support@leadiq.com